2 months abrdn plc Sells 21,181 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK) MarketBeat
abrdn plc trimmed its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 5.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 348,056 shares of the biopharmaceutical company’…
X